Patents by Inventor Mina Tsukamoto

Mina Tsukamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR PAIN
    Publication number: 20170327474
    Abstract: [Problem] Provided is a pharmaceutical, in particular, a pharmaceutical composition which is useful for the treatment of pain. [Means for Solution] The present inventors have made extensive studies using model animals with pain for the purpose of providing a therapeutic agent for pain. As a result, they have found that 11?-hydroxydehydrogenase type 1 (11?-HSD1) inhibitor, in particular, a triazole compound having a cyclic group at the 3-position (or 5-position) of a triazole ring has a good effect of ameliorating chronic pain. That is, according to the present invention, a pharmaceutical composition comprising an 11?-HSD1 inhibitor, in particular, the triazole compound of the present invention, as an active ingredient, is useful for the treatment of pain (particularly, neuropathic pain or fibromyalgia).
    Type: Application
    Filed: July 31, 2017
    Publication date: November 16, 2017
    Applicant: ASTELLAS PHARMA INC.
    Inventors: Tetsuo KISO, Mina TSUKAMOTO
  • Therapeutic agent for pain
    Patent number: 9765040
    Abstract: [Problem] Provided is a pharmaceutical, in particular, a pharmaceutical composition which is useful for the treatment of pain. [Means for Solution] The present inventors have made extensive studies using model animals with pain for the purpose of providing a therapeutic agent for pain. As a result, they have found that 11?-hydroxydehydrogenase type 1 (11?-HSD1) inhibitor, in particular, a triazole compound having a cyclic group at the 3-position (or 5-position) of a triazole ring has a good effect of ameliorating chronic pain. That is, according to the present invention, a pharmaceutical composition comprising an 11?-HSD1 inhibitor, in particular, the triazole compound of the present invention, as an active ingredient, is useful for the treatment of pain (particularly, neuropathic pain or fibromyalgia).
    Type: Grant
    Filed: September 6, 2011
    Date of Patent: September 19, 2017
    Assignee: Astellas Pharma Inc.
    Inventors: Tetsuo Kiso, Mina Tsukamoto
  • THERAPEUTIC AGENT FOR PAIN
    Publication number: 20130165491
    Abstract: [Problem] Provided is a pharmaceutical, in particular, a pharmaceutical composition which is useful for the treatment of pain. [Means for Solution] The present inventors have made extensive studies using model animals with pain for the purpose of providing a therapeutic agent for pain. As a result, they have found that 11?-hydroxydehydrogenase type 1 (11?-HSD1) inhibitor, in particular, a triazole compound having a cyclic group at the 3-position (or 5-position) of a triazole ring has a good effect of ameliorating chronic pain. That is, according to the present invention, a pharmaceutical composition comprising an 11?-HSD1 inhibitor, in particular, the triazole compound of the present invention, as an active ingredient, is useful for the treatment of pain (particularly, neuropathic pain or fibromyalgia).
    Type: Application
    Filed: September 6, 2010
    Publication date: June 27, 2013
    Applicant: ASTELLAS PHARMA INC.
    Inventors: Tetsuo Kiso, Mina Tsukamoto
  • AGENT FOR TREATING FIBROMYALGIA
    Publication number: 20120253036
    Abstract: An agent for treating fibromyalgia containing a 5-HT2C receptor agonist as an active ingredient
    Type: Application
    Filed: December 10, 2010
    Publication date: October 4, 2012
    Inventors: Yukinori Nagakura, Mina Tsukamoto, Tomonari Watabiki